Cepton Benzoyl Peroxide 5% W/W Gel
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Benzoyl Peroxide 5% Gel
Cepton Benzoyl Peroxide 5% w/w Gel
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Benzoyl Peroxide 5%.
3 PHARMACEUTICAL FORM
Gel
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
All stages of acne vulgaris.
4.2 Posology and method of administration
Adults
Treatment should be initiated with Benzoyl Peroxide 5%. gel once daily the affected areas should be washed with soap and water and then dried before Benzoyl Peroxide 5%. gel is applied. For stubborn cases treatment may be continued with Benzoyl Peroxide 10%. gel provided that Benzoyl Peroxide 5%. gel has been well tolerated. For particularly sensitive skin, Benzoyl Peroxide 5%. gel should be applied on alternate days.
Children Not applicable
The Elderly: Not applicable.
4.3 Contraindications
Known hypersensitivity to benzoyl peroxide.
4.4 Special warnings and precautions for use
Avoid contact with eyes and mucosae. If the skin is exposed to strong or prolonged sunlight, Benzoyl Peroxide gel should be applied at longer intervals and a highly protective sun-screening agent should be used. Benzoyl Peroxide gel should only be applied to dry skin to avoid unnecessary irritation.
For external use only. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.
4.5 Interaction with other medicinal products and other forms of interaction
This is an oxidising agent, therefore it should not be used at the same time as other topical agents, which would react with an oxidising agent.
4.6 Fertility, Pregnancy and lactation
The normal use of Benzoyl Peroxide gel is not contraindicated during pregnancy.
4.7 Effects on ability to drive and use machines
Not applicable.
4.8 Undesirable effects
As with all keratolytic substances itching reddening burning and a feeling of skin tension may occur. This may be relieved by the use of a moisturising cream or by temporary interruption of the use.
In rare cases a contact dermatitis occur in which event treatment should be stopped immediately.
Face Oedema.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
4.9 Overdose
Not applicable.
5.1 Pharmacodynamic properties
Benzoyl peroxide has a strong antibacterial action against propioni-bacterium acnes. It is has keratolytic and sebostatic, which cause some dryness and desquamation.
5.2 Pharmacokinetic properties
None stated.
5.3 Preclinical safety data
None stated.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Carbomer 980, Polyoxyethylene 23 Lauryl Ether, Propylene Glycol, Sodium Hydroxide and Purified water
6.2 Incompatibilities
This is an oxydising agent, therefore it should not be used at the same time as other topical agents , which would react with an oxidising agent.
6.3 Shelf life
24 months
6.4 Special precautions for storage
Store below 25’C
6.5 Nature and contents of container
Low density polyethylene tubes 30g
Low density polyethylene tubes 40g
6.6 Special precautions for disposal
No Data Held
7 MARKETING AUTHORISATION HOLDER
Boston Healthcare Limited Unit 6, Navigation Court Calder Park Wakefield
West Yorkshire WF2 7BJ United Kingdom
8 MARKETING AUTHORISATION NUMBER(S)
PL 39974/0017
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
31st January 2005
10 DATE OF REVISION OF THE TEXT
17/07/2015